Covered recipient · General Payments record
BRANDY FLEISCHER
General Payments · PY2022–2024
$1,356.83
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $522.70 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $253.84 | 21 |
| Madrigal Pharmaceuticals | $119.29 | 1 |
| QOL Medical, LLC | $49.82 | 3 |
| Janssen Biotech, Inc. | $27.53 | 1 |
| Medtronic, Inc. | $21.88 | 1 |
| Celgene Corporation | $17.83 | 1 |
| PFIZER INC. | $17.77 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.14 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110211 | CMS |
| ABBVIE INC. | $0.24 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110213 | CMS |
| ABBVIE INC. | $15.25 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110215 | CMS |
| ABBVIE INC. | $14.55 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110217 | CMS |
| ABBVIE INC. | $0.25 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110219 | CMS |
| ABBVIE INC. | $1.88 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110221 | CMS |
| ABBVIE INC. | $21.15 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110223 | CMS |
| ABBVIE INC. | $14.28 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110225 | CMS |
| ABBVIE INC. | $0.30 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110227 | CMS |
| ABBVIE INC. | $1.53 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110229 | CMS |
| ABBVIE INC. | $13.64 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110231 | CMS |
| ABBVIE INC. | $25.36 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110233 | CMS |
| ABBVIE INC. | $3.02 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110235 | CMS |
| ABBVIE INC. | $1.67 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110237 | CMS |
| ABBVIE INC. | $22.33 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110239 | CMS |
| ABBVIE INC. | $8.80 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110241 | CMS |
| ABBVIE INC. | $20.06 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110243 | CMS |
| ABBVIE INC. | $24.22 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110245 | CMS |
| ABBVIE INC. | $22.27 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110247 | CMS |
| ABBVIE INC. | $3.20 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110249 | CMS |
| ABBVIE INC. | $14.70 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107110251 | CMS |
| Celgene Corporation | $17.83 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101145577 | CMS |
| Janssen Biotech, Inc. | $27.53 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078804079 | CMS |
| Madrigal Pharmaceuticals | $119.29 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144190674 | CMS |
| Medtronic, Inc. | $21.88 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116863112 | CMS |
| PFIZER INC. | $17.77 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131425482 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.74 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151165382 | CMS |
| QOL Medical, LLC | $13.32 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147736678 | CMS |
| QOL Medical, LLC | $17.35 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147736680 | CMS |
| QOL Medical, LLC | $19.15 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147736682 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.